Sign In
Buy QTRX
$3.22
-0.270 (-7.74%)
At Close: Jun 23, 2026
Quanterix Announces Closing of Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
03:12pm, Monday, 08'th Feb 2021
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the closing of its previous
Quanterix Prices Public Offering of Common Stock
07:00am, Thursday, 04'th Feb 2021
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the pricing of its previous
Quanterix Announces Proposed Public Offering of $200.0 Million of its Common Stock
04:25pm, Wednesday, 03'rd Feb 2021
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it has commenced an un
Quanterix to Participate in PMWC 2021 COVID-19 Conference
03:39pm, Friday, 22'nd Jan 2021
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced Chairman, Chief Executive O
Quanterix stock jumps nearly 10% after company gets EUA for COVID-19 test
06:03pm, Monday, 11'th Jan 2021
Shares of Quanterix Corp. rallied nearly 10% in the extended session Monday after the life-sciences company said the Food and Drug Administration has issued an emergency use authorization for the comp
Quanterix Receives FDA Emergency Use Authorization for SARS-CoV-2 N Protein Antigen Test
04:30pm, Monday, 11'th Jan 2021
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that the Food and Drug Admin
Quanterix Corporation to Present At 39th Annual J.P. Morgan Healthcare Conference
04:06pm, Wednesday, 06'th Jan 2021
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that its Chairman, Chief Ex
Quanterix Receives FDA Emergency Use Authorization for Semi-Quantitative Antibody Test
06:46pm, Monday, 28'th Dec 2020
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that the Food and Drug Admi
Quanterix to Participate in the Canaccord Medical Technologies and Diagnostics Forum
12:36pm, Friday, 13'th Nov 2020
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced Chairman, Chief Executive O
Quanterix Corporation's (QTRX) CEO Kevin Hrusovsky on Q3 2020 Results - Earnings Call Transcript
11:29pm, Sunday, 08'th Nov 2020
Quanterix Corporation's (QTRX) CEO Kevin Hrusovsky on Q3 2020 Results - Earnings Call Transcript
Kevin Hrusovsky to Speak at Precision Medicine Leaders Summit's Precision Oncology Conference
11:37am, Wednesday, 28'th Oct 2020
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that its Chairman, Chief Ex
